Rani Therapeutics Holdings Inc (RANI)

Jan 17, 2025

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $11.71 Consensus PT from Brokerages - MarketBeat

Jan 17, 2025

Jan 17, 2025

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $11.71 Consensus Target Price from Analysts - Defense World

Jan 17, 2025

Jan 14, 2025

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $11.71 Average Target Price from Brokerages - MarketBeat

Jan 14, 2025

Jan 13, 2025

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Shares Purchased by Geode Capital Management LLC - Defense World

Jan 13, 2025

Jan 10, 2025

Rani Therapeutics stock hits 52-week low at $1.29 - Investing.com India

Jan 10, 2025

Jan 10, 2025

Rani Therapeutics stock hits 52-week low at $1.29 By Investing.com - Investing.com South Africa

Jan 10, 2025

Dec 27, 2024

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Shares Acquired by Stifel Financial Corp - Defense World

Dec 27, 2024

Dec 23, 2024

Analysts Set Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Target Price at $11.71 - Defense World

Dec 23, 2024

Dec 20, 2024

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $11.71 Average PT from Brokerages - MarketBeat

Dec 20, 2024

Dec 19, 2024

Rani Therapeutics stock hits 52-week low at $1.32 - Investing.com

Dec 19, 2024

Dec 17, 2024

Insider Buying: Kate Mckinley Acquires Shares in Rani Therapeuti - GuruFocus.com

Dec 17, 2024

Dec 16, 2024

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Insider Kate Mckinley Acquires 17,960 Shares - MarketBeat

Dec 16, 2024

Dec 11, 2024

Rani Therapeutics stock hits 52-week low at $1.85 By Investing.com - Investing.com Nigeria

Dec 11, 2024

Dec 11, 2024

Rani Therapeutics stock hits 52-week low at $1.85 - Investing.com India

Dec 11, 2024

Dec 10, 2024

CEO Talat Imran Acquires Additional Shares of Rani Therapeutics Holdings Inc (RANI) - GuruFocus.com

Dec 10, 2024

Dec 03, 2024

Rani Therapeutics stock hits 52-week low at $1.94 By Investing.com - Investing.com Nigeria

Dec 03, 2024

Dec 02, 2024

Rani Therapeutics stock hits 52-week low at $1.94 - Investing.com India

Dec 02, 2024

Nov 28, 2024

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $11.71 Average Target Price from Analysts - Defense World

Nov 28, 2024

Nov 25, 2024

Brokerages Set Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Price Target at $11.71 - MarketBeat

Nov 25, 2024

Nov 25, 2024

What is Zacks Small Cap’s Forecast for RANI FY2024 Earnings? - Defense World

Nov 25, 2024

Nov 25, 2024

What is Zacks Small Cap's Forecast for RANI FY2024 Earnings? - MarketBeat

Nov 25, 2024

Nov 20, 2024

RANI: Third Quarter Update - MSN

Nov 20, 2024

Nov 19, 2024

Rani Therapeutics' (RANI) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Nov 19, 2024

Nov 18, 2024

Rani Therapeutics Advances in Biotherapeutics Market - TipRanks

Nov 18, 2024

Nov 15, 2024

Rani Therapeutics Holdings Inc (RANI) Quarterly 10-Q Report - Quartzy

Nov 15, 2024

Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in Rani Therapeutics H - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update - The Manila Times

Nov 14, 2024

Nov 14, 2024

Rani Therapeutics Slashes Q3 Loss by 31%, Secures $20M Funding for GLP-1 Development | RANI Stock News - StockTitan

Nov 14, 2024

Nov 07, 2024

Rani Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Nov 07, 2024

Nov 03, 2024

Brokerages Set Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) PT at $11.71 - Defense World

Nov 03, 2024

Oct 25, 2024

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Sees Significant Growth in Short Interest - MarketBeat

Oct 25, 2024

Oct 23, 2024

Allied Gaming & Entertainment And 2 Other US Penny Stocks To Watch - Simply Wall St

Oct 23, 2024

Oct 22, 2024

RANI: New Triagonist Data in Weight Loss - Zacks Small Cap Research

Oct 22, 2024

Oct 19, 2024

Rani Therapeutics shares hold buy rating on positive preclinical data By Investing.com - Investing.com Australia

Oct 19, 2024

Oct 19, 2024

Rani Therapeutics stock gets positive outlook from H.C. Wainwright after novel obesity candidate progress - Investing.com Australia

Oct 19, 2024

Oct 19, 2024

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.75% - MSN

Oct 19, 2024

Oct 18, 2024

Rani Therapeutics shares hold buy rating on positive preclinical data - Investing.com

Oct 18, 2024

Oct 18, 2024

Rani Therapeutics (NASDAQ:RANI) Receives "Buy" Rating from HC Wainwright - MarketBeat

Oct 18, 2024